ARQT
Arcutis Biotherapeutics, Inc. Common Stock
$25.29
-4.31%
-1.14
Notify me if price changes either direction
Buy ARQT stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
3.2B
Enterprise value
3.3B
Trailing PE
-194.53846858098
Forward PE
23.320658
PEG Ratio
3.5370630651087
Enterprise to EBITDA
90.718
Enterprise to revenue
7.167
Price to book MRQ
17.422544
Price to sales TTM
7.159859
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
464.0M
EBITDA
1.8M
Diluted EPS TTM
-0.02
Total Cash (MRQ)
238.6M
Current ratio (MRQ)
2.917
Operating Cash Flow (TTM)
-5625000
ARQT trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
August 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
